Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [912]
News [3692]
Articles [22]
Editorials [1]
Conferences [136]
elearning [0]
Pivotal study supports belzutifan approval for patients with advanced kidney cancer
Pivotal study supports belzutifan approval for patients with advanced kidney cancer
Unlocking the potential of targeted therapies for multiple myeloma
Unlocking the potential of targeted therapies for multiple myeloma
Precision therapy for metastatic prostate cancer improves survival
Precision therapy for metastatic prostate cancer improves survival
New anti-CKAP4 antibodies deliver hope for pancreatic cancer treatment
New anti-CKAP4 antibodies deliver hope for pancreatic cancer treatment
Neoadjuvant immunotherapy may facilitate surgery and improve outcomes for patients with high-risk liver cancer
Neoadjuvant immunotherapy may facilitate surgery and improve outcomes for patients with high-risk liver cancer
Two new studies show how immunotherapies collaborate to boost T cell responses in melanoma
Two new studies show how immunotherapies collaborate to boost T cell responses in melanoma
The heightened importance of EZH2 in cancer immunotherapy
The heightened importance of EZH2 in cancer immunotherapy
Tpex cells: the game-changer in targeted tumour immunotherapy
Tpex cells: the game-changer in targeted tumour immunotherapy
How does an effective cancer therapy damage the heart?
How does an effective cancer therapy damage the heart?
Meteorin-like protein drains energy from T cells, limiting immune system’s power to fight cancer
Meteorin-like protein drains energy from T cells, limiting immune system’s power to fight cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation